Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Anti-radiation Drugs Market to reach USD 9.6 Billion by 2032.

Global Anti-radiation Drugs Market Size study, by Compound (Potassium Iodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate), Others), by Application (Acute Radiation Syndrome (ARS), Cancer Treatment, Radiation Exposure, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Regional Forecasts 2022-2032

Product Code: HLSDT-68726216
Publish Date: 25-08-2024
Page: 200

The global Anti-radiation Drugs Market was valued at approximately USD 4.11 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.9% over the forecast period 2024-2032. Anti-radiation drugs offer protection against radiation exposure. These drugs include KI, Prussian Blue, and DTPA (Diethylenetriamine pentaacetate). Anti-radiation medicines help block the absorption and subsequent concentration of radioactive iodine in the thyroid gland. KI must be consumed before or shortly after exposure to radioactive iodine for better results. It is effective only against radioactive iodine and not against other types of radiation. Oxidation of ferrous ferrocyanide salts produces Prussian blue, which is used for the treatment of thallium poisoning or radioactive cesium poisoning.

The high prevalence of cancer and Acute Radiation Syndrome (ARS) is driving the anti-radiation drugs business. Potassium iodide (KI), an anti-radiation drug, provides some protection in cases of radiation exposure. The rise in concerns regarding the usage of nuclear weapons in wars is expected to augment the demand for anti-radiation pills. Detonation of a nuclear weapon may lead to the release of radioactive iodine. Biotechnology firms are receiving government contracts to develop drugs for the treatment of ARS. Vendors in the anti-radiation drugs sector are investing significantly in expanding their production capabilities. They are also launching new products to broaden their Anti-radiation Drugs Market share.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. North America is the dominating and fastest-growing region in the Anti-radiation Drugs Market. This leadership is driven by several key factors. The region’s advanced healthcare infrastructure, coupled with significant government investments in defense and emergency preparedness, has spurred demand for anti-radiation drugs. The United States, in particular, has seen substantial funding directed towards stockpiling and research of these drugs as part of national security measures against potential nuclear threats or radiological emergencies. Additionally, the presence of leading pharmaceutical companies and research institutions in North America contributes to rapid advancements in drug development and commercialization. The increasing awareness of radiation risks, both from potential nuclear incidents and from medical radiation exposure, further boosts the market. Regulatory support and accelerated approval processes for emergency use drugs also play a crucial role in the region’s dominance and fast-paced growth in the global Anti-radiation Drugs Market.

Major market players included in this report are:
Amgen Inc.
Anbex Inc.
Arco Pharmaceuticals LLC
BTG International Inc.
Cellphire, Inc.
Chrysalis BioTherapeutics, Inc.
Darnitsa
Enzychem Lifesciences Corporation
Humanetics Corporation
Mission Pharmacal Company
Myelo Therapeutics GmbH
Partner Therapeutics
Pluri Inc.
Jubilant Life Sciences Ltd.

The detailed segments and sub-segment of the market are explained below:
By Compound:
Potassium Iodide (KI)
Prussian Blue
DTPA (Diethylenetriamine Pentaacetate)
Others

By Application:
Acute Radiation Syndrome (ARS)
Cancer Treatment
Radiation Exposure
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others

By Region:
North America
U.S.
Canada

Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacifc

Latin America
Brazil
Mexico
Rest of Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:
Historical year – 2021-2022
Base year – 2023
Forecast period – 2022 to 2023

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Anti-radiation Drugs Market Executive Summary
1.1. Global Anti-radiation Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Compound
1.3.2. By Application
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Anti-radiation Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Anti-radiation Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Increase in Risk of Radiological and Nuclear Incidents
3.1.2. Rise in R&D of Radiopharmaceuticals
3.2. Market Challenges
3.2.1. High Cost of Drug Development
3.2.2. Regulatory Hurdles
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Investment in New Product Development

Chapter 4. Global Anti-radiation Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Anti-radiation Drugs Market Size & Forecasts by Compound 2022-2032
5.1. Segment Dashboard
5.2. Global Anti-radiation Drugs Market: Compound Revenue Trend Analysis, 2022 & 2032(USD Billion)
5.2.1. Potassium Iodide (KI)
5.2.2. Prussian Blue
5.2.3. DTPA (Diethylenetriamine Pentaacetate)
5.2.4. Others

Chapter 6. Global Anti-radiation Drugs Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Anti-radiation Drugs Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
6.2.1. Acute Radiation Syndrome (ARS)
6.2.2. Cancer Treatment
6.2.3. Radiation Exposure
6.2.4. Others

Chapter 7. Global Anti-radiation Drugs Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Anti-radiation Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Others

Chapter 8. Global Anti-radiation Drugs Market Size & Forecasts by Region 2022-2032
8.1. North America Anti-radiation Drugs Market
8.1.1. U.S. Anti-radiation Drugs Market
8.1.1.1. Compound breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Anti-radiation Drugs Market

8.2. Europe Anti-radiation Drugs Market
8.2.1. Germany Anti-radiation Drugs Market
8.2.2. U.K. Anti-radiation Drugs Market
8.2.3. France Anti-radiation Drugs Market
8.2.4. Italy Anti-radiation Drugs Market
8.2.5. Rest of Europe Anti-radiation Drugs Market

8.3. Asia-Pacific Anti-radiation Drugs Market
8.3.1. China Anti-radiation Drugs Market
8.3.2. Japan Anti-radiation Drugs Market
8.3.3. India Anti-radiation Drugs Market
8.3.4. Rest of Asia-Pacific Anti-radiation Drugs Market

8.4. Latin America Anti-radiation Drugs Market
8.4.1. Brazil Anti-radiation Drugs Market
8.4.2. Mexico Anti-radiation Drugs Market
8.4.3 Rest of Latin America Anti-radiation Drugs Market

8.5. Middle East and Africa Anti-radiation Drugs Market
8.5.1. Saudi Arabia Anti-radiation Drugs Market
8.5.2. South Africa Anti-radiation Drugs Market
8.5.3. Rest of Latin America Anti-radiation Drugs Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Amgen Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Anbex Inc.
9.3.3. Arco Pharmaceuticals LLC
9.3.4. BTG International Inc.
9.3.5. Cellphire, Inc.
9.3.6. Chrysalis BioTherapeutics, Inc.
9.3.7. Darnitsa
9.3.8. Enzychem Lifesciences Corporation
9.3.9. Humanetics Corporation
9.3.10. Mission Pharmacal Company
9.3.11. Myelo Therapeutics GmbH
9.3.12. Partner Therapeutics
9.3.13. Pluri Inc.
9.3.14. Emergent BioSolutions Inc.
9.3.15. Jubilant Life Sciences

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now